# US 2016/0251344 A1 · Novel crystalline form of 2-piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulphonate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0251344 A1
- Document ID: US20160251344A1
- Status: Published application
- Kind: A1
- Application number: 15/028,923
- Filed: 2014-10-13
- Published: 2016-09-01
- Earliest claimed: 2013-10-17
- Assignees: Bayer CropScience AG
- Applicants: Bayer Cropscience Aktiengesellschaft
- Inventors: Britta OLENIK; Stefan HILLEBRAND; Pierre WASNAIRE; Martin WEISS; Ulrike WACHENDORFF-NEUMANN
- Web page: https://patentgrep.com/patent/US20160251344A1

## CPC

- C07D 417/14: containing three or more hetero rings
- A01N 43/80: five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The present invention relates to a novel crystalline form of 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethansulphonate, to processes for its preparation and to its use in agrochemical preparations.

## Claims

### Claim 1

Crystalline form of 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethansulphonate, wherein an X-ray powder diffractogram thereof at 25° C. has at least 3 of the following 2θ (2 theta) values:
2θ=7.75°±0.2
2θ=8.89±0.2
2θ=10.91±0.2
2θ=11.45±0.2
2θ=12.72±0.2
2θ=13.46±0.2
2θ=14.54±0.2
2θ=14.75±0.2
2θ=15.53±0.2
2θ=15.90±0.2
2θ=16.33±0.2
2θ=16.65±0.2
2θ=17.49±0.2
2θ=17.71±0.2
2θ=17.89±0.2
2θ=18.27±0.2
2θ=18.47±0.2
2θ=18.86±0.2
2θ=18.99±0.2
2θ=19.18±0.2
2θ=19.63±0.2
2θ=20.03±0.2
2θ=20.22±0.2
2θ=20.53±0.2
2θ=21.11±0.2
2θ=21.32±0.2
2θ=21.50±0.2
2θ=21.84±0.2
2θ=22.01±0.2
2θ=22.28±0.2
2θ=22.61±0.2
2θ=23.05±0.2
2θ=23.39±0.2
2θ=24.02±0.2
2θ=24.22±0.2
2θ=24.62±0.2
2θ=24.97±0.2
2θ=25.59±0.2
2θ=25.99±0.2
2θ=26.31±0.2
2θ=26.67±0.2
2θ=26.85±0.2
2θ=27.07±0.2
2θ=27.43±0.2
2θ=28.21±0.2
2θ=28.34±0.2
2θ=28.78±0.2
2θ=29.59±0.2
2θ=30.19±0.2
2θ=30.37±0.2
2θ=30.96±0.2
2θ=31.29±0.2
2θ=31.70±0.2
2θ=31.81±0.2
2θ=32.16±0.2
2θ=33.02±0.2
2θ=33.39±0.2
2θ=33.64±0.2
2θ=33.79±0.2
2θ=33.80±0.2
2θ=34.20±0.2
2θ=34.77±0.2
2θ=34.89±0.2
2θ=35.66±0.2
2θ=35.95±0.2
2θ=36.67±0.2
2θ=37.03±0.2
2θ=37.38±0.2
2θ=37.51±0.2
2θ=37.87±0.2

### Claim 2 (depends on 1)

Crystalline form according to claim 1, wherein said X-ray powder diffractogram at 25° C. has at least 4 of said 2θ values.

### Claim 3 (depends on 1)

Composition, comprising the novel solid form according to claim 1 and one or more suitable auxiliaries.

### Claim 4 (depends on 1)

A crystalline form according to claim 1 capable of being used for preparing a composition for controlling plant-pathogenic harmful fungi in and/or on a plant and/or in and/or on seed of plants.

### Claim 5 (depends on 1)

Use of the A crystalline form according to claim 1 capable of being used for treating seed.

### Claim 6 (depends on 1)

Method for controlling plant-pathogenic harmful fungi in and/or on plants or in and/or on seed of plants, comprising applying the crystalline form according to claim 1 to the plant-pathogenic harmful fungi and/or a habitat thereof and/or to seed.

### Claim 7 (depends on 1)

Process for preparing the compound as defined in claim 1 comprising:
(a) suspending amorphous 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulphonate in a solvent or solvent mixture at temperature of at least 50° C. and
(b) slowly cooling the suspension.

### Claim 8 (depends on 7)

Process according to claim 7, in which the slow cooling is undertaken stepwise.

### Claim 9 (depends on 7)

Process according to claim 7, in which the solvent or solvent mixture used is selected from the group consisting of isopropanol, toluene, methyl-THF, diethyl carbonate, chlorobenzene, n-butyl acetate and isobutyl acetate, n-butanol, ethanol, ethyl malonate, methyl t-butyl ether, and also mixtures of toluene and butanol, toluene and n-butyl acetate, ethyl malonate and methyl t-butyl ether, and butyl acetate and methyl t-butyl ether.

### Claim 10 (depends on 8)

Process according to claim 8, in which the solvent used is isopropanol.
